for the German Chemo-N0 Study Group. Level-I evidence for prognostic and predictive impact of uPA and PAI-1 in node-negative breast cancer provided by second scheduled analysis of multicenter Chemo-N0 therapy trial - Harbeck, N; Meisner, C; Prechtl, A (Breast Cancer Res Treat, 2001)
et al.